PBH FY 2017 Earnings Report — Prestige Consumer Healthcare Inc. Revenue & Financial Results | Market Cap Arena

Prestige Consumer Healthcare Inc.PBH

FY 2017 Earnings

Reported May 17, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$882M	—	$806M	—	9.4%
Op. Income	$206M	—	$260M	—	-21.0%
Gross Margin	56.7%	—	57.9%	—	-1.2pp
Net Margin	7.9%	—	12.4%	—	-4.5pp
EPS (Diluted)	$1.30	—	$1.88	—	-30.9%
Free Cash Flow	$145M	—	$171M	—	-15.2%

Revenue Flow

Item	Amount
REVENUE	$882M
Cost of Revenue	$382M
GROSS PROFIT	$500M
R&D Expenses	$0
Selling & Marketing	$128M
General & Administrative	$89M
SG&A Expenses	$218M
Other Expenses	$25M
Operating Expenses	$243M
Cost & Expenses	$625M
OPERATING INCOME	$206M
Interest Income	$203.0K
Interest Expense	$94M
Other Income/Expenses	-$95M
INCOME BEFORE TAX	$111M
Income Tax Expense	$41M
Net Income from Continuing Ops	$69M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$69M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$69M
D&A	$26M
EBIT	$204M
EBITDA	$304M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$882M
Cost of Revenue	$382M
GROSS PROFIT	$500M
R&D Expenses	$0
Selling & Marketing	$128M
General & Administrative	$89M
SG&A Expenses	$218M
Other Expenses	$25M
Operating Expenses	$243M
Cost & Expenses	$625M
OPERATING INCOME	$206M
Interest Income	$203.0K
Interest Expense	$94M
Other Income/Expenses	-$95M
INCOME BEFORE TAX	$111M
Income Tax Expense	$41M
Net Income from Continuing Ops	$69M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$69M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$69M
D&A	$26M
EBIT	$204M
EBITDA	$304M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$69M
Depreciation & Amortization	$26M
Stock-Based Compensation	$8M
Deferred Income Tax	-$6M
Other Non-Cash Items	$64M
Change in Working Capital	-$13M
OPERATING CASH FLOW	$148M
Capital Expenditure	-$3M
Acquisitions (Net)	-$693M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$2M
NET CASH FROM INVESTING	-$695M
Net Debt Issuance	$570M
Common Stock Repurchased	-$1M
Common Dividends Paid	$0
Other Financing Activities	-$6M
NET CASH FROM FINANCING	$562M
FREE CASH FLOW	$145M
Net Change in Cash	$15M

Balance Sheet

Item	Amount
Cash & Equivalents	$42M
Short-Term Investments	$0
Net Receivables	$137M
Inventory	$116M
Other Current Assets	$40M
TOTAL CURRENT ASSETS	$334M
PP&E (Net)	$51M
Goodwill	$615M
Intangible Assets	$2.9B
Long-Term Investments	-$715M
Tax Assets	$715M
Other Non-Current Assets	$7M
TOTAL NON-CURRENT ASSETS	$3.6B
TOTAL ASSETS	$3.9B
Account Payables	$70M
Short-Term Debt	$0
Deferred Revenue	$492.0K
Other Current Liabilities	$23M
TOTAL CURRENT LIABILITIES	$162M
Long-Term Debt	$2.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$715M
Other Non-Current Liabilities	$18M
TOTAL NON-CURRENT LIABILITIES	$2.9B
TOTAL LIABILITIES	$3.1B
Common Stock	$533.0K
Additional Paid-In Capital	$458M
Retained Earnings	$397M
Treasury Stock	-$7M
Accum. Other Comp. Income	-$26M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$823M
Minority Interest	$0
TOTAL EQUITY	$823M
TOTAL LIABILITIES & EQUITY	$3.9B
Total Debt	$2.2B
Net Debt	$2.2B